Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1991 Nov 2;303(6810):1084–1085. doi: 10.1136/bmj.303.6810.1084

Salt substitutes and potassium intake.

J D Swales
PMCID: PMC1671298  PMID: 1747573

Full text

PDF
1084

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cappuccio F. P., MacGregor G. A. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens. 1991 May;9(5):465–473. doi: 10.1097/00004872-199105000-00011. [DOI] [PubMed] [Google Scholar]
  2. Carlsen J. E., Køber L., Torp-Pedersen C., Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. 1990 Apr 14;300(6730):975–978. doi: 10.1136/bmj.300.6730.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Easterbrook P. J., Berlin J. A., Gopalan R., Matthews D. R. Publication bias in clinical research. Lancet. 1991 Apr 13;337(8746):867–872. doi: 10.1016/0140-6736(91)90201-y. [DOI] [PubMed] [Google Scholar]
  4. Goldszer R. C., Coodley E. L., Rosner M. J., Simons W. M., Schwartz A. B. Hyperkalemia associated with indomethacin. Arch Intern Med. 1981 May;141(6):802–804. [PubMed] [Google Scholar]
  5. Harrington J. T., Isner J. M., Kassirer J. P. Our national obsession with potassium. Am J Med. 1982 Aug;73(2):155–159. doi: 10.1016/0002-9343(82)90171-1. [DOI] [PubMed] [Google Scholar]
  6. Hoyt R. E. Hyperkalemia due to salt substitutes. JAMA. 1986 Oct 3;256(13):1726–1726. [PubMed] [Google Scholar]
  7. Khaw K. T., Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med. 1987 Jan 29;316(5):235–240. doi: 10.1056/NEJM198701293160502. [DOI] [PubMed] [Google Scholar]
  8. Lawson D. H. Adverse reactions to potassium chloride. Q J Med. 1974 Jul;43(171):433–440. [PubMed] [Google Scholar]
  9. MacCarthy E. P., Frost G. W., Strokes G. S. Indomethacin-induced hyperkalaemia. Med J Aust. 1979 Jun 16;1(12):550–550. doi: 10.5694/j.1326-5377.1979.tb127061.x. [DOI] [PubMed] [Google Scholar]
  10. McCaughan D. Hazards of non-prescription potassium supplements. Lancet. 1984 Mar 3;1(8375):513–514. doi: 10.1016/s0140-6736(84)92883-6. [DOI] [PubMed] [Google Scholar]
  11. Robertson J. W., Isles C. G., Brown I., Cameron H. L., Coley H., Lever A. F., Murray G. D. Mild hypokalaemia is not a risk factor in treated hypertensives. J Hypertens. 1986 Oct;4(5):603–608. doi: 10.1097/00004872-198610000-00013. [DOI] [PubMed] [Google Scholar]
  12. Snyder E. L., Dixon T., Bresnitz E. Letter: Abuse of salt "substitute". N Engl J Med. 1975 Feb 6;292(6):320–320. doi: 10.1056/NEJM197502062920623. [DOI] [PubMed] [Google Scholar]
  13. Tan S. Y., Shapiro R., Franco R., Stockard H., Mulrow P. J. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med. 1979 May;90(5):783–785. doi: 10.7326/0003-4819-90-5-783. [DOI] [PubMed] [Google Scholar]
  14. Tannen R. L. Diuretic-induced hypokalemia. Kidney Int. 1985 Dec;28(6):988–1000. doi: 10.1038/ki.1985.229. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES